Quest Diagnostics Inc (DGX) stock
DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/3011% above fair value
$262.21+2.61 (+1.01%)
Close on Nov 16, 2026Market cap $28.85BP/E 26.1Yield –
Quest Diagnostics cash
Cash and short-term investments held at the end of each period.
Quest Diagnostics's cash was $797.00M at Sep 30, 2026. For fiscal 2025 it was $420.00M, down 23.5% from the year before. Over ten years it grew 12.2% a year on average. The highest annual figure on record is $1.19B in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $420.00M | -23.5% |
| FY2024 | Dec 31, 2024 | $549.00M | -20.0% |
| FY2023 | Dec 31, 2023 | $686.00M | +117.8% |
| FY2022 | Dec 31, 2022 | $315.00M | -63.9% |
| FY2021 | Dec 31, 2021 | $872.00M | -24.7% |
| FY2020 | Dec 31, 2020 | $1.16B | -2.9% |
| FY2019 | Dec 31, 2019 | $1.19B | +783.0% |
| FY2018 | Dec 31, 2018 | $135.00M | -1.5% |
| FY2017 | Dec 31, 2017 | $137.00M | -64.3% |
| FY2016 | Dec 31, 2016 | $384.00M | +188.7% |
| FY2015 | Dec 31, 2015 | $133.00M | -30.7% |
| FY2014 | Dec 31, 2014 | $192.00M | +2.7% |
| FY2013 | Dec 31, 2013 | $187.00M | -36.8% |
| FY2012 | Dec 31, 2012 | $296.00M | +79.4% |
| FY2011 | Dec 31, 2011 | $165.00M | -63.3% |
| FY2010 | Dec 31, 2010 | $449.00M | -16.0% |
| FY2009 | Dec 31, 2009 | $534.26M | +110.4% |
| FY2008 | Dec 31, 2008 | $253.95M | +51.5% |
| FY2007 | Dec 31, 2007 | $167.59M | +12.0% |
| FY2006 | Dec 31, 2006 | $149.64M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $797.00M | +84.5% |
| Q2 FY2026 | Jun 30, 2026 | $626.00M | +96.2% |
| Q1 FY2026 | Mar 31, 2026 | $393.00M | +109.0% |
| Q4 FY2025 | Dec 31, 2025 | $420.00M | -23.5% |
| Q3 FY2025 | Sep 30, 2025 | $432.00M | -43.5% |
| Q2 FY2025 | Jun 30, 2025 | $319.00M | +17.7% |
| Q1 FY2025 | Mar 31, 2025 | $188.00M | -60.3% |
| Q4 FY2024 | Dec 31, 2024 | $549.00M | -20.0% |
| Q3 FY2024 | Sep 30, 2024 | $764.00M | +434.3% |
| Q2 FY2024 | Jun 30, 2024 | $271.00M | +115.1% |
| Q1 FY2024 | Mar 31, 2024 | $474.00M | +170.9% |
| Q4 FY2023 | Dec 31, 2023 | $686.00M | +117.8% |
| Q3 FY2023 | Sep 30, 2023 | $143.00M | -79.6% |
| Q2 FY2023 | Jun 30, 2023 | $126.00M | -84.1% |
| Q1 FY2023 | Mar 31, 2023 | $175.00M | -75.4% |
| Q4 FY2022 | Dec 31, 2022 | $315.00M | -63.9% |
| Q3 FY2022 | Sep 30, 2022 | $700.00M | -29.1% |
| Q2 FY2022 | Jun 30, 2022 | $790.00M | +41.1% |
| Q1 FY2022 | Mar 31, 2022 | $712.00M | -42.1% |
| Q4 FY2021 | Dec 31, 2021 | $872.00M | -24.7% |
| Q3 FY2021 | Sep 30, 2021 | $987.00M | -38.5% |
| Q2 FY2021 | Jun 30, 2021 | $560.00M | -43.3% |
| Q1 FY2021 | Mar 31, 2021 | $1.23B | +259.6% |
| Q4 FY2020 | Dec 31, 2020 | $1.16B | -2.9% |
| Q3 FY2020 | Sep 30, 2020 | $1.61B | +269.8% |
| Q2 FY2020 | Jun 30, 2020 | $988.00M | +261.9% |
| Q1 FY2020 | Mar 31, 2020 | $342.00M | -26.3% |
| Q4 FY2019 | Dec 31, 2019 | $1.19B | +783.0% |
| Q3 FY2019 | Sep 30, 2019 | $434.00M | +65.0% |
| Q2 FY2019 | Jun 30, 2019 | $273.00M | +106.8% |
| Q1 FY2019 | Mar 31, 2019 | $464.00M | +274.2% |
| Q4 FY2018 | Dec 31, 2018 | $135.00M | -1.5% |
| Q3 FY2018 | Sep 30, 2018 | $263.00M | -24.9% |
| Q2 FY2018 | Jun 30, 2018 | $132.00M | -58.0% |
| Q1 FY2018 | Mar 31, 2018 | $124.00M | -66.2% |
| Q4 FY2017 | Dec 31, 2017 | $137.00M | -64.3% |
| Q3 FY2017 | Sep 30, 2017 | $350.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $314.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $367.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $384.00M | – |
See a number that looks wrong?